Tickerplace logo

Tickerplace

CRISPR Therapeutics AG logo

CRSPCRISPR Therapeutics AG

CRSP Stock Price, Valuation & Chart | CRISPR Therapeutics AG

Compare
$49.390-0.60 (-1.20%)

At close · 23 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

CRSP Historical price chart

CRSP Key Stats

Market Capitalization4.78B
PE Ratio-10.38
EPS-4.76
Trading Volume1.92M
Today's High/Low49.64/48.02
Dividend Yield0.00
52 Week High/Low68.71/44.12
Shares Outstanding96.69M
CRSP Financial Statement
CRSP Analyst ratings
CRSP Analysis & performance metrics

CRSP Company profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short…

CRSP Management team

Management
Daniel G. Anderson Ph.D.
Scientific Founder & Advisory Board Member
Matthew Porteus M.D., Ph.D.
Scientific Founder & Advisory Board Member
Craig C. Mello Ph.D.
Scientific Founder & Advisory Board Member
Raju Yashaswi Prasad Ph.D.CFO
Chief Financial Officer
Samarth Kulkarni Ph.D.CEO
Chief Executive Officer & Chairman
James R. Kasinger J.D.
General Counsel & Secretary
Naimish Patel C.M., M.D.
Chief Medical Officer
Shaun Foy CFA
Founder
Total 8 executives

CRSP Frequently asked questions

What is CRISPR Therapeutics AG (CRSP) Stock Price?

Current stock price of CRISPR Therapeutics AG (CRSP) stock is $49.390. The stock price is -1.20% lower in the session. The intraday range can be seen from this page. Volume of CRISPR Therapeutics AG (CRSP) stock is 1.92M.

Last updated at 23 Oct 2026, 08:00 pm.

Why is the CRISPR Therapeutics AG (CRSP) stock price going up or down today?

The stock price of CRISPR Therapeutics AG (CRSP) can change with earnings, company news, and overall market sentiment. CRISPR Therapeutics AG operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CRISPR Therapeutics AG stock expensive at its current price?

Whether CRISPR Therapeutics AG looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRSP on this page is -10.38. EPS on this page is -4.76. Compare those figures with peers and growth expectations before deciding if the current CRISPR Therapeutics AG price is justified.

How has the stock price of CRISPR Therapeutics AG (CRSP) performed historically?

Historical performance for CRISPR Therapeutics AG (CRSP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRSP reacted to past earnings and market events.

Should I buy CRISPR Therapeutics AG (CRSP) stock, at this price?

Buying CRISPR Therapeutics AG (CRSP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.